---
title: 'Senior Scientist, Translational Research at Triveni Bio'
canonical: 'https://feeny.ai/job/senior-scientist-translational-research-triveni-bio-watertown-da1x7eetc8zm'
type: 'job'
last_seen: '2026-10-17'
---

# Senior Scientist, Translational Research at Triveni Bio

- **Company:** Triveni Bio
- **Location:** Watertown, MA
- **Compensation:** $67–$72/hr
- **Employment:** contract
- **Work type:** onsite
- **Posted:** 2026-10-02
- **Last confirmed live:** 2026-10-17
- **Apply:** https://jobs.lever.co/trivenibio/20b90222-0a6d-4782-b9d0-df2f947bfb63

## Job description

## COMPANY INTRODUCTION

Triveni Bio is breaking new ground in the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine.  We are pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for the treatment of immunological and inflammatory (I&I) disorders. Our lead antibody program (TRIV-509) targets kallikreins 5 and 7 (KLK5/7) to directly impact skin barrier function, inflammation, and itch – providing a meaningful and much needed potential treatment option for patients with atopic dermatitis and other barrier disorders. In all the work we do, we adhere to our core values: patient impact, bold and rigorous science, open collaboration, kindness & respect.

## SUMMARY

Triveni Bio is seeking a highly motivated and experienced Scientist to join our Biology and Translational Research team. In this role, you will lead image-based biomarker analyses and drive the experimental design and execution of cell-based and ex vivo preclinical models. This is an exciting opportunity to shape the scientific biomarker strategy across multiple indications, advancing therapeutics that target novel disease pathways. If you are passionate about therapeutic discovery and possess extensive expertise in image analysis, we want to hear from you.

## RESPONSIBILITIES

- Lead image-based biomarker analyses using HALO to support biomarker analyses
- Design and execute experimental cell-based and ex vivo preclinical models
- Oversee external research activities, to meet timelines, deliverables, and data quality with Contract Research Organizations (CROs) or academic collaborators

## EXPERIENCE & QUALIFICATIONS

- Ph.D. in molecular biology or related a related discipline with 5+ years of experience within the pharmaceutical or biotechnology sectors.
- Extensive, hands-on expertise in image analysis utilizing HALO.
- Solid background in Immunology and Inflammation indications, with a strong preference for specific experience in atopic dermatitis.
- Familiarity or expertise in mechanistic cell-based and cell-free assays to investigate type 2 immunity, including immune cells, mast cells, IgE biology, cytokine modulation, and other relevant pharmacodynamic readouts.
- Proven track record of effectively managing Contract Research Organizations (CROs), external vendors, and academic collaborators.

The posted range reflects the current reasonable and good faith estimate for this position. Actual compensation will be based on a variety of factors including, but not limited to, relevant skills and experience, educational background and certifications, performance and qualifications, market demand for the role, geographic location and other organizational needs.

We are committed to fair pay practices, and we regularly review our compensation programs to ensure they are competitive, equitable, and aligned with our values. Please note that the advertised pay range is not a guarantee or promise of a specific wage.

Triveni Bio, along with other biotech companies, has become aware of a surge in email scams targeting prospective job candidates within our industry. Official Triveni Bio applications will always be submitted through Lever, our ATS. Any applications that take you to other platforms could be fraudulent. We do not use text or chat applications to conduct interviews or make job offers. Official Triveni Bio correspondence will always be conducted from email addresses ending in @triveni.bio or @hire.lever.co. Please disregard any other communications that do not originate from these domain names. If you receive any suspicious requests or communications, please verify their authenticity before responding.

## About Triveni Bio

## Company Overview
- **One-liner**: Triveni Bio is a clinical-stage biotechnology company applying a genetics-informed precision medicine approach to develop functional antibodies for immune and inflammatory (I&I) disorders.
- **Entity Type**: Private (Series C; total funding $223.4M)
- **Headquarters**: Watertown, Massachusetts, United States
- **Founded**: Not publicly available (earliest funding round was Series A in 2020)
- **Founders**: Not publicly available (key leadership includes CEO Vishal Patel, CSO Jennifer Dovey [founding employee], CMO Bhaskar Srivastava, COO Nicholas Scarchilli)

## Core Business
- Primary industry: Biotechnology (therapeutics for inflammatory and immune-mediated diseases)
- Target customers: Patients with I&I disorders, physicians, and pharmaceutical partners (B2B + B2C model)
- Mission statement: "Our measure of success is the impact we have on patients."

## Products & Services
- **TRIV-509** – A first-in-class, dual-specific, half-life extended monoclonal antibody that inhibits active kallikreins 5 and 7 (KLK5/7). Currently in Phase 2 clinical trials for moderate-to-severe atopic dermatitis, with potential expansion into eosinophilic esophagitis (EoE) and epidermal differentiation disorders (EDD). (Therapeutic antibody – biologic)
- **TRIV-573** – A second-generation bispecific antibody combining dual inhibition of KLK5/7 with an anti-IL‑13 mechanism. Currently in Phase 1, with plans to initiate a Phase 2 proof-of-concept trial in moderate-to-severe atopic dermatitis in the second half of 2026. (Therapeutic antibody – bispecific)
- **TRIV-920** – A first-in-class monoclonal antibody targeting trypsin 1 and 2 for the treatment of pancreatitis (preclinical stage). (Therapeutic antibody – first-in-class)

## Market Standing
- **Valuation**: Not disclosed
- **Key Metric**: Total funding of $223.4M (3 rounds: Series A $16.4M in 2020, Series A‑2 $92M in 2023, Series B $115M in 2024, and an undisclosed Series C led by Janus Henderson Investors and Ascenta Capital in 2026)
- **Notable Investors/Partners**: Atlas Venture, Cormorant Asset Management, Goldman Sachs Alternatives, Janus Henderson Investors, Ascenta Capital
- **Growth Signals**: 43.6% year-over-year headcount growth (now 47 employees); expanded into new headquarters in Watertown, MA; advanced TRIV‑509 into Phase 2; initiated first human studies for TRIV‑573; raised Series C to broaden clinical studies and drive company growth.

## Competitive Advantages
- **Genetics‑informed target selection**: Uses integrated multi‑omic datasets and “knowledge graphs” to identify disease drivers (e.g., KLK5/7 in atopic dermatitis) and leverage both risk and protective alleles.
- **Advanced antibody engineering**: Developed a single monoclonal antibody that binds both KLK5 and KLK7 with equal potency, overcomes historic targeting challenges, and includes half‑life extension for convenient dosing.
- **First‑in‑class potential**: TRIV‑920 addresses pancreatitis, a condition with no approved therapies, showing preclinical reduction of pancreatic damage markers.

## Strategic Focus
- Advance TRIV‑573 through Phase 2 proof‑of‑concept in atopic dermatitis (2H 2026).
- Expand TRIV‑509 into additional indications (EoE, EDD).
- Continue preclinical development of TRIV‑920 for pancreatitis.
- Scale the organization while maintaining a collaborative, patient‑focused culture.

## Why Work Here
- **Culture**: Described as “bold & rigorous,” collaborative, and kind, with a strong emphasis on patient impact. Employees note that leadership actively listens and creates a safe space for ideas.
- **Location**: On-site in Watertown, MA (newly expanded headquarters) with an additional office in Waltham.
- **Work Environment**: Clinical‑stage biotech with exciting science; opportunity to “make medicines for patients in need alongside colleagues pushing the boundaries of science and medicine.”
- **Perks**: Not explicitly detailed, but the organization values “curious minds” and “drive to turn ideas into impact.”

## Sources
1. [triveni.bio/about](https://triveni.bio/about/)
2. [triveni.bio/pipeline](https://triveni.bio/pipeline/)
3. [triveni.bio/science](https://triveni.bio/science/)
4. [linkedin.com/company/triveni-bio](https://linkedin.com/company/triveni-bio)
5. [jobs.lever.co/trivenibio](https://jobs.lever.co/trivenibio)

## Other roles at Triveni Bio

- [Associate Director, IT](https://feeny.ai/job/associate-director-it-triveni-bio-watertown-bxzhfa1gzw4c) — Watertown, MA
- [Senior Director, Clinical Development](https://feeny.ai/job/senior-director-clinical-development-triveni-bio-watertown-6zqvzj0pe16q) — Watertown, MA
- [Director, AI and Data Science](https://feeny.ai/job/director-ai-and-data-science-triveni-bio-watertown-hny7b1d8bar4) — Watertown, MA